unyango lomhlaza wesibeleko se-psma

Unyango lwe-PSMA lomhlaza wesibeleko imele inkqubela phambili ebalulekileyo ekulawulweni komhlaza wedlala lesidoda, ngakumbi umhlaza wedlala lesidoda omelana ne-metastatic castration (mCRPC). Esi sikhokelo siphonononga okwahlukileyo Unyango lwe-PSMA lomhlaza wesibeleko iinketho, kubandakanywa unyango radioligand, ukusebenza kwabo, iziphumo ebezingalindelekanga, kwaye batshintsha njani imo yokhathalelo lomhlaza wesinyi. Funda malunga nesayensi emva kwe-PSMA, iindlela ezahlukeneyo zonyango ezikhoyo, kunye neziphi izigulane ezinokulindela ngexesha lokunyanga.Ukuqonda i-PSMA kunye nendima yayo kwi-Prostate CancerProstate-Specific Membrane Antigen (PSMA) yiprotheyini ebonakaliswa kakhulu kumphezulu weeseli zomhlaza we-prostate, ngakumbi kwi-Advanced and Metastatic disease. Oku kwenza i-PSMA ibe yinto egqwesileyo ekujoliswe kuyo kumfanekiso wokuxilonga kunye nonyango olujoliswe kuyo.Iyintoni i-PSMA?I-PSMA yiprotheni ye-transmembrane esebenza njenge-glutamate carboxypeptidase. Ngelixa indima yayo yomzimba isaphandwa, kuyaziwa ukuba intetho ye-PSMA iphezulu kakhulu kwiiseli zomhlaza we-prostate xa kuthelekiswa nezicubu eziqhelekileyo zesinyi kunye nezinye iiseli emzimbeni. Oku kuchazwa ngokugqithisileyo kwenza kube yinto ekujoliswe kuyo ekucingeni umhlaza wedlala lesinyi kunye nonyango.Kutheni i-PSMA iSijoliso esiLungileyo soNyango loMhlaza weProstate?Inkcazo ephezulu ye-PSMA kwiiseli zomhlaza wedlala lobudoda ivumela ukujoliswa okukhethiweyo, ukunciphisa umonakalo kwizicubu eziphilileyo. Olu khetho lubalulekile ekunciphiseni iziphumo ebezingalindelekanga kunye nokuphucula isalathiso sonyango lonyango lomhlaza wesibeleko. Ngaphaya koko, ukubonakaliswa kwe-PSMA kuthambekele ekunyukeni njengoko umhlaza we-prostate uqhubela phambili, oko kuyenza ibe yinto ekujoliswe kuyo exabisekileyo nakwinqanaba eliphezulu lesi sifo. Unyango lwe-PSMA lomhlaza wesibeleko iindlela ziye zaphuhliswa, zisebenzisa iimpawu ezizodwa ze-PSMA ukuhambisa ii-agent zonyango ngokuthe ngqo kwiiseli zomhlaza we-prostate.I-PSMA-Targeted Radioligand Therapy (RLT) Unyango lwe-radioligand olujoliswe kwi-PSMA lubandakanya ukudibanisa i-isotope ye-radioactive kwi-molecule ebophelela ngokukodwa kwi-PSMA. Le radiopharmaceutical ke itofwe kwisigulana, apho ijikeleza egazini kwaye ngokukhetha ibophelela kwi-PSMA-ebonisa iiseli zomhlaza wedlala lesinyi. I-isotope ye-radioactive ikhupha imitha eyonakalisa okanye ebulala iiseli zomhlaza. Umzekelo obalaseleyo yiLutetium-177 (177Lu) PSMA-617.Isebenza njani: I-molecule ejoliswe kuyo (umzekelo, i-PSMA-617) ibophelela kwi-PSMA kwiiseli zomhlaza we-prostate. I-isotope ye-radioactive (umzekelo, i-Lutetium-177) ihambisa imitha kwiiseli zomhlaza. Imitha yemitha iyonakalisa iDNA yeeseli zomhlaza, ikhokelela ekufeni kweeseli.Ukusebenza: Izilingo zeklinikhi zibonise ukusebenza kwe-PSMA ekujoliswe kuyo kwi-RLT ekuphuculeni ukusinda ngokubanzi kunye nomgangatho wobomi kwizigulane ezine-mCRPC. Uvavanyo lwe-VISION, umzekelo, lubonise inzuzo ebalulekileyo yokuphila kunye ne-177Lu-PSMA-617 kunye nomgangatho wokunyamekela ngokuthelekiswa nomgangatho wokunyamekela yedwa. Ndwendwela IZiko loPhando ngoMhlaza laseShandong Baofa ukufunda ngakumbi malunga nokuhambela phambili kunyango lomhlaza.Iziphumo ebezingalindelekanga: Imiphumo eqhelekileyo ye-PSMA ejoliswe kuyo i-RLT ibandakanya ukukhathala, umlomo owomileyo, isicaphucaphu, ukunyanzeliswa komongo wethambo (okukhokelela kwinani eliphantsi legazi), kunye neengxaki zezintso. Ezi ziphumo bezingalindelekanga zilawuleka ngokubanzi ngokhathalelo oluxhasayo.I-PSMA-Targeted Antibody-Drug Conjugates (ADCs)I-antibody-drug conjugates iquka i-antibody ebophelela kwi-PSMA, edityaniswe neyeza elinamandla lechemotherapy. Nje ukuba i-antibody ibophe kwi-PSMA kwiseli yomhlaza, i-ADC ifakwe ngaphakathi, kwaye iyeza le-chemotherapy likhutshwa ngaphakathi kwiseli, liyibulale.Isebenza njani: I-antibody ibophelela kwi-PSMA kwiiseli zomhlaza wedlala lesidoda. I-ADC ifakwe ngaphakathi kwiseli. Iyeza lechemotherapy likhutshwa ngaphakathi kwiseli, likhokelela ekufeni kweeseli.Ukusebenza: Ii-ADC ezijoliswe kwi-PSMA zisaphantsi kophuhliso, kodwa ulingo lwezonyango lwakwangoko lubonise iziphumo ezithembisayo kwizigulane ezine-mCRPC. Ukusebenza kunokwahluka ngokuxhomekeke kwi-ADC ethile kunye neempawu zesigulane.Iziphumo ebezingalindelekanga: Imiphumo emibi ixhomekeke kwiyeza le-chemotherapy elisetyenziswe kwi-ADC kwaye ingabandakanya isicathulo, ukukhathala, ukulahleka kweenwele, kunye nokunciphisa umongo wethambo.I-PSMA-Targeted Imaging kunye neTheranosticsPSMA-i-imaging ejoliswe kuyo ibandakanya ukusebenzisa i-radioactive tracers ebophelela kwi-PSMA ukujonga iiseli zomhlaza we-prostate usebenzisa i-PET / CT scans. Oku kuvumela oogqirha ukuba bachonge indawo kunye nobungakanani besifo, bavavanye impendulo kunyango, kwaye bakhethe izigulane ezinokuthi zixhamle kwiindlela zonyango ezijoliswe kwi-PSMA. Le ndlela ingumzekelo we-theranostics, ukudibanisa ukuxilongwa kunye nonyango.Isebenza njani: I-tracer ye-radioactive (umzekelo, i-Gallium-68 PSMA-11 okanye i-Fluorine-18 DCFPyL) ijojowe kwisigulane. Umkhondo ubophelela kwi-PSMA kwiiseli zomhlaza wedlala lesinyi. I-PET / CT scan yenziwa ukujonga indawo kunye nobukhulu besifo.Ukusebenza: I-imaging ejoliswe kwi-PSMA inovelwano kakhulu kwaye ikhethekileyo ekubhaqeni umhlaza wedlala lesinyi, kubandakanywa ne-metastases. Iyakwazi ukubona isifo esingabonakaliyo kwiindlela eziqhelekileyo zomfanekiso. Olu lwazi lunokukhokela izigqibo zonyango kunye nokuphucula iziphumo zesigulane.Iziphumo ebezingalindelekanga: I-imaging ejoliswe kwi-PSMA ikhuselekile ngokubanzi, ineziphumo ebezingalindelekanga ezincinci. Iitracer zeradioactive ezisetyenzisiweyo zinesiqingatha sobomi obufutshane kwaye zikhutshwa ngokukhawuleza emzimbeni.Ngubani uMgqatswa we-PSMA-Targeted Therapy?Unyango lwe-PSMA lomhlaza wesibeleko Ngokuqhelekileyo kuthathelwa ingqalelo izigulana ezinomhlaza wedlala lobudoda obunganyangekiyo kwi-metastatic castration (mCRPC) abaye baqhubela phambili kunyango olusemgangathweni olufana nonyango lokuvimba i-androgen kunye nechemotherapy. Abaviwa abafanelekileyo banembonakalo ephezulu ye-PSMA kumathumba abo, njengoko kumiselwa yi-PSMA-PET imaging.Iinqobo zokuKhetha isigulana Ukukhetha isigulane Unyango lwe-PSMA lomhlaza wesibeleko ibalulekile ekwandiseni ukusebenza ngempumelelo kunye nokunciphisa umngcipheko weziphumo ebezingalindelekanga. Iikhrayitheriya eziphambili zibandakanya: I-Metastatic castration-resistant prostate cancer (mCRPC) Ukuqhubela phambili kunyango oluqhelekileyo (umzekelo, unyango lwe-androgen lwe-deprivation, i-chemotherapy) Ukubonakaliswa kwe-PSMA ephezulu kwi-tumor, njengoko kunqunywe ngumfanekiso we-PSMA-PET Umsebenzi owaneleyo wezintso kunye nomongo wethamboIndima ye-PSMA-PET Imaging ku-Treatment Planning nge-PET idlala indima ebalulekileyo ekucwangciseni unyango nge-PET idlala indima ebalulekileyo ekucwangciseni unyango. Unyango olujoliswe kwi-PSMA. Izigulane ezinenkcazo ephezulu ye-PSMA kwii-tumors zabo ziyakwazi ukuphendula kunyango, ngelixa abo banenkcazo ephantsi ye-PSMA abanako ukuxhamla.Yintoni enokuyilindela ngexesha le-PSMA-Targeted TherapyAmava okuqhuba Unyango lwe-PSMA lomhlaza wesibeleko inokwahluka ngokuxhomekeke kunyango oluthile olusetyenzisiweyo. Nangona kunjalo, kukho imiba eqhelekileyo ekufuneka uyiqaphele.ULawulo loNyango kunye nokuBeka esweni i-RLT ethagethiweyo yePSMA ivamise ukulawulwa ngomthambo wegazi kwisigulana esingaphandle. Izigulana zinokufumana imijikelo yonyango emininzi, ihlukaniswe iiveki ezininzi. Ngethuba lokunyanga, izigulane zijongwa ngokusondeleyo kwimiphumo emibi kunye nokuphendula kunyango.Iimpembelelo ezinokuthi zibekho kunye noLawuloNjengoko kukhankanywe ngaphambili, iziphumo eziqhelekileyo zeendlela zonyango ezijoliswe kwi-PSMA ziquka ukukhathala, umlomo owomileyo, isicaphucaphu, ukunyanzeliswa komnkantsha, kunye neengxaki zezintso. Ezi ziphumo bezingalindelekanga zilawuleka ngokubanzi ngokhathalelo oluxhasayo, njengamayeza okuphelisa isicaphucaphu kunye neentlungu, utofelo-gazi lokunyanga i-anemia, kunye ne-hydration ukuxhasa ukusebenza kwezintso. Ukuhlolwa rhoqo kobalo lwegazi kunye nokusebenza kwezintso kubalulekile ngexesha lonyango.Ikamva le-PSMA-Targeted TherapyTherapy Unyango lwe-PSMA lomhlaza wesibeleko ikhula ngokukhawuleza, kunye nophando oluqhubekayo oluhlola iindlela ezintsha zonyango kunye nokuphucula unyango.Uphando oluqhubekayo kunye nezilingo zeklinikhiAbaphandi baphanda ama-radioligand amatsha ajoliswe kwi-PSMA kunye nokusebenza okuphuculweyo kunye neeprofayili zokhuseleko. Unyango oludityanisiweyo, olufana nokudibanisa i-PSMA-ejoliswe kwi-RLT kunye nolunye unyango olufana nonyango lwe-immunotherapy okanye ichemotherapy, nalo luyaphononongwa. IZiko loPhando ngoMhlaza laseShandong Baofa uzibophelele ekuhlaleni phambili kwezi nkqubela phambili.Uphuhliso olunokubakho kwi-PSMA-Ekujongwe kuNyango Inkqubela phambili yekamva kunyango olujoliswe kwi-PSMA inokubandakanya: Iisotophu ezinamandla ngakumbi zeradioactive Ukuphuculwa kweemolekyuli zokujolisa kunye nobudlelwane obuphezulu be-PSMA Unyango oluDityanisiweyo oluphucula ukusebenza kakuhle kweempawu zonyango ezijoliswe kwi-PSMA Personalized Personality RLT kunye ne-PPS ye-Personal Unyango loMhlaza: IsishwankatheloUnyango lwe-PSMA lomhlaza wesibeleko imele indlela ethembisayo yokulawula umhlaza wedlala lesinyi. Ngokujolisa ngokukhethayo kwi-PSMA-echaza iiseli zomhlaza wedlala lengqula, olu nyango lunokuphucula iziphumo kunye nomgangatho wobomi kwizigulana ezine-mCRPC. Njengoko uphando luqhubeka, sinokulindela ukubona inkqubela phambili kweli candelo, ekhokelela kunyango olusebenzayo ngakumbi nolwenzelwe wena lomhlaza wedlala lesinyi. Ukuthelekiswa kwe-PSMA-Ejoliswe kwiintlobo zonyango zonyango Uhlobo loNyango Indlela yoNyango Umzekelo oPhambili Isimo I-PSMA-Targeted Radioligand Therapy (RLT) Ihambisa i-radiation ngqo kwi-PSMA-ebonisa iiseli i-Lutetium-177 (177Lu) i-PSMA-617 eVunyiweyo kwi-mCRPC I-PSMA-Druged Concepts Antijustable to chemotherapy I-PSMA-ebonisa iiseli (Ezahlukeneyo - phantsi kophuhliso) Iimvavanyo zekliniki I-PSMA-Targeted Imaging Visualize PSMA expression for diagnostic and treatment planning Gallium-68 PSMA-11, Fluorine-18 DCFPyL Approved for Imaging I-Disclaimer: Le ngcaciso yenzelwe iinjongo zemfundo kuphela kwaye akufanele ithathwe njengengcebiso yezonyango. Nceda udibane nengcali yezempilo eqeqeshiweyo ukuze ufumane ukuxilongwa kunye nonyango.